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Abstract
Individuals suffering from ﬁbrocystic disease may acquire non-
tuberculous mycobacteria as colonizing or infecting organisms.
Mycobacterium abscessus is of particular concern because it may
be very difﬁcult to eradicate and may mitigate against lung trans-
plantation. However, this species may be difﬁcult to reliably dif-
ferentiate from the closely related M. chelonae. We have
developed a rapid, low-cost, short sequence-based technique to
conﬁrm species identity by analysis of a segment of the RNA
Polymerase B (rpoB) gene.
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Cystic ﬁbrosis is a life-shortening genetic disease, which is
particularly prevalent in people of European/Caucasian heri-
tage. The disease affects secretory cells and in severe forms
causes progressive disability and often early death. Respira-
tory problems are common and are exacerbated by frequent
lung infections. In severely affected individuals lung transplan-
tation becomes a last resort. Fitness for transplantation
involves several factors but infection with M. abscessus is
often held to presage a poor outcome and thus become a
disqualifying factor for this life-saving step [1]. In contrast,
M. chelonae infection is not held to be of similar signiﬁcance.
Thus, accurate separation of these species may have consid-
erable clinical signiﬁcance [2].
There are currently 138 validly named species of myco-
bacteria. Although the majority of the ‘slow growing’ species
have pathogenic potential, most ‘fast-growers’ are exclusively
environmental. However, a few fast-growers can also be
opportunistic pathogens, notably members of the Mycobacte-
rium chelonae clade, including M. abscessus. Other closely
related species in the clade include M. massiliense [3], M. bol-
letii [4] and recently M. franklinii [5], which have been shown
to demonstrate different clinical signiﬁcance [6–8]. These are
soil and water organisms that can occur in the human gut
and may be present on the skin surface. Both species have
been causative of wound infections but are unlikely systemic
pathogens due to their low optimum growth temperature.
However, vulnerable individuals with pre-existing lung condi-
tions may become colonized.
FIG. 1. DNA strip technology result. Lane 1: M. chelonae. Lane 2–4:
M. abscessus.
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Though now seen as separate species [9], M. abscessus
and M. chelonae were previously thought to be synonymous.
The two species are largely indistinguishable phenotypically
(both species grow as rough or smooth non-chromogenic or
buff-coloured colonies on standard media in 3–4 days and
prefer lower temperatures of around 33C) and chemo-
taxonomically [10] and also share almost identical 16S rDNA
sequences (three base pairs difference across the whole
gene, Nehren, Germany), but are separable in DNA:DNA
homology analyses. Although resistant to most anti-TB and
conventional chemotherapeutic agents, M. chelonae is sufﬁ-
ciently susceptible to some to allow successful treatment.
However, M. abscessus is often resistant to a wide range of
agents and is very difﬁcult to eradicate [11].
Various methods have been used in characterization of
these two species; differentiation is commonly aided by the
use of DNA strip technology, which targets a region of the
ITS gene (GenoType Myocobacterium AS, Hain Lifescience,
Nehren, Germany). This system of three related kits is
designed to classify organisms of the M. tuberculosis complex,
17 other mycobacteria and if necessary, an additional 13 spe-
cies. However, the distinction between M. abscessus and
M. chelonae can be tenuous and is often a subjective decision.
The aim of this work was to develop a more suitable tool for
the accurate identiﬁcation and differentiation of these two
species.
Isolates from 100 ﬁbrocystic patients presumptively identi-
ﬁed using phenotypic characteristics and DNA strip technol-
ogy as either M. abscessus or M. chelonae were collected and
the DNA extracted by boiling for 5 min. Published sequences
of housekeeping genes for the two species were compared
to determine areas of variance suitable for a differential assay
[12–14]. A segment of the RNA Polymerase B (rpoB) gene
was found to be suitable and Pyrosequencing was used to
determine the sequence of a 60 base-pair portion of the rpoB
gene [15]. This sequence is located in variable region II
according to the numbering of Ade´kambi et al., at position
1105-1219 (including primer sequences) [16]. Of 100 isolates
in this pilot study, 99 were successfully sequenced and the
data analysed. Of 94 presumptively identiﬁed using DNA
strip technology as M. chelonae (Fig. 1), 55 (59%) were con-
ﬁrmed as this species but 39 (41%) were classiﬁed as
M. abscessus by rpoB sequence analysis (Fig. 2). Of ﬁve iso-
lates presumptively identiﬁed as M. abscessus, four were con-
ﬁrmed as M. abscessus but one strain was found to classify as
M. chelonae. The correct identiﬁcation of fast-growing myco-
bacteria isolated from vulnerable individuals, particularly cys-
tic ﬁbrosis sufferers, is of considerable importance.
However, accurate identiﬁcation of such closely related spe-
cies presents a signiﬁcant challenge, especially in the light of
some current thinking regarding lateral gene transfer of rpoB
in mycobacteria [17]. The technique we have developed and
described here offers the promise of a rapid, short-
sequence-based, low-cost assay to effectively meet this chal-
lenge. Next steps include the examination of more of these
species from patients with cystic ﬁbrosis and subjecting
selected strains to an extended analysis of concatenated
genes, including 16S rrs and hsp65 to conﬁrm their identity.
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